Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6301
Global X Alternative Income ETF
ALTY
$45.4M
| $57K | ﹤0.01% |
4,586
-1
| -0% | -$12 |
2023 Q3
11 quarters
|
|
6302
Cohen & Steers Real Estate Active ETF
CSRE
$573M
| $56.8K | ﹤0.01% |
2,001
+2,000
| +200,000% | +$56.7K |
2026 Q1
1 quarter
|
|
6303
Hyperfine
HYPR
$98.7M
| $56.7K | ﹤0.01% |
42,032
+30,032
| +250% | +$43.4K |
2025 Q4
2 quarters
|
|
6304
Inspire International ETF
WWJD
$558M
| $56.6K | ﹤0.01% |
1,485
-477
| -24% | -$18.6K |
2024 Q1
9 quarters
|
|
6305
VinFast Auto
VFS
$7.16B
| $56.6K | ﹤0.01% |
18,146
+6,594
| +57% | +$24.8K |
2023 Q3
11 quarters
|
|
6306
Crawford & Co Class B
CRD.B
$572M
| $56.6K | ﹤0.01% |
5,424
+4,268
| +369% | +$43K |
2020 Q3
23 quarters
|
|
6307
Freedom Day Dividend ETF
MBOX
$150M
| $56K | ﹤0.01% |
1,394
-9,423
| -87% | -$367K |
2025 Q2
4 quarters
|
|
6308
Tortoise AI Infrastructure ETF
TCAI
$242M
| $55.9K | ﹤0.01% |
+1,000
| New | +$48.3K |
2026 Q2
0 quarters
|
|
6309
Moleculin Biotech
MBRX
$9.01M
| $55.9K | ﹤0.01% |
20,036
+20,000
| +55,556% | +$51.1K |
2021 Q1
21 quarters
|
|
6310
PMV Pharmaceuticals
PMVP
$81.3M
| $55.9K | ﹤0.01% |
41,684
-822,627
| -95% | -$1.06M |
2020 Q3
23 quarters
|
|
6311
Calamos S&P 500 Structured Alt Protection ETF - October
CPSO
$28.5M
| $55.7K | ﹤0.01% |
2,000
| – | – |
2025 Q2
4 quarters
|
|
6312
Calamos S&P 500 Structured Alt Protection ETF - November
CPSN
$34M
| $55.4K | ﹤0.01% |
2,000
| – | – |
2025 Q2
4 quarters
|
|
6313
AOT Growth and Innovation ETF
AOTG
$111M
| $55.4K | ﹤0.01% |
846
| – | – |
2024 Q3
7 quarters
|
|
6314
Inovio Pharmaceuticals
INO
$119M
| $55.3K | ﹤0.01% |
50,256
-13,608
| -21% | -$16.1K |
2013 Q2
52 quarters
|
|
6315
MicroSectors Gold Miners 3x Leveraged ETN
GDXU
$928M
| $55K | ﹤0.01% |
645
-93,377
| -99% | -$15.6M |
2025 Q2
4 quarters
|
|
6316
DELISTED
Siren DIVCON Leaders Dividend ETF
LEAD
| $55K | ﹤0.01% |
600
+300
| +100% | +$25.6K |
2024 Q1
9 quarters
|
|
6317
Franklin Municipal Green Bond ETF
FLMB
$53.6M
| $54.9K | ﹤0.01% |
2,281
-420
| -16% | -$10K |
2024 Q4
6 quarters
|
|
6318
Cheetah Mobile
CMCM
$77M
| $54.9K | ﹤0.01% |
18,164
-15,316
| -46% | -$72.9K |
2014 Q2
48 quarters
|
|
6319
Strategas Macro Thematic Opportunities ETF
SAMT
$805M
| $54.9K | ﹤0.01% |
1,149
+177
| +18% | +$7.82K |
2025 Q3
3 quarters
|
|
6320
Militia Long/Short Equity ETF
ORR
$348M
| $54.5K | ﹤0.01% |
1,500
| – | – |
2025 Q1
5 quarters
|
|
6321
Simplify Tara India Opportunities ETF
IOPP
$6.8M
| $54.2K | ﹤0.01% |
+2,091
| New | +$52.5K |
2026 Q2
0 quarters
|
|
6322
Dimensional Inflation-Protected Securities ETF
DFIP
$1.11B
| $54.2K | ﹤0.01% |
1,313
-29
| -2% | -$1.21K |
2024 Q2
8 quarters
|
|
6323
Valhi
VHI
$402M
| $54.1K | ﹤0.01% |
3,689
-1,998
| -35% | -$28.2K |
2013 Q2
52 quarters
|
|
6324
DELISTED
LHA Risk-Managed Income ETF
RMIF
| $54.1K | ﹤0.01% |
2,237
| – | – |
2024 Q1
9 quarters
|
|
6325
Hartford Total Return Bond ETF
HTRB
$2.16B
| $53.7K | ﹤0.01% |
1,591
+397
| +33% | +$13.4K |
2022 Q4
14 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.